Merck-Kelun ADC outperforms Keytruda in trial, a closely watched Parkinson’s drug fails, and more biotech news from The ...

The Trump administration disclosed plans to reduce state directed payments even more, setting up a probable showdown with ...

Far fewer knew that mpox and Zika can also be transmitted sexually. And most respondents understood the main ways that these ...

Supporters worry that a men’s health office created by the Trump administration risks being dismantled by a future Democratic ...

The company behind the analytics, Vizient, touts MGH's increasing hospice enrollment to improved mortality performance.

With no approved vaccine for the fast-growing Ebola outbreak in the DRC, experts weigh testing one with unknown protection.

A type of targeted chemotherapy developed by China-based Kelun-Biotech and licensed to Merck cut the risk of tumor ...

Biogen and Denali Therapeutics said a closely watched experimental therapy for Parkinson’s disease failed to slow the ...

Biogen and Denali said their experimental Parkinson’s therapy failed to slow the degenerative brain disorder in a randomized ...

In response to an Ebola outbreak, the U.S. has banned entry for noncitizens who have been in the Democratic Republic of the ...

My patients are replacing olive oil with beef tallow, even if they don't tell me during cardiac rehab,” writes a clinical ...

The check-in and “intake” at one’s medical appointment should be restructured to function like the self-check-in at the ...